This document provides an overview of neurologic disorders that can affect the maxillofacial region. It discusses sensory disturbances such as trigeminal neuralgia and various classifications of nerve injuries. It also covers motor disturbances like Bell's palsy. Trigeminal neuralgia is characterized by intense, stabbing pain in the face that is triggered by light touch. Bell's palsy causes sudden, unilateral facial paralysis of unknown cause. The document outlines evaluation, diagnosis, and management approaches for various neurologic conditions affecting the face and jaws.
clinical assessment and treatment of oral malodour and halitosis.
includes microorganisms causing halitosis, volatile sulphur compounds and its relation to periodontal destruction.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.
clinical assessment and treatment of oral malodour and halitosis.
includes microorganisms causing halitosis, volatile sulphur compounds and its relation to periodontal destruction.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.
Cancer of the oral cavity accounts for approximately 3% of all malignancies diagnosed annually in 270,000 patients world-wide. Oral cancer is the 12th most common cancer in women and the 6th in men. Many oral squamous cell carcinomas develop from potentially malignant disorders (PMDs). Lack of awareness about the signs and symptoms of oral PMDs in the general population and even healthcare providers is believed to be responsible for the diagnostic delay of these entities.
Gingivitis is a form of gum disease characterised by reversible gingival inflammation without destruction of tooth-supporting tissues, periodontal ligament or bone
Headache Attributed to Nonvascular, Noninfectious
Intracranial Disorders
Headache Attributed to Trauma or Injury to the Head
and/or Neck
Headache Attributed to Infection
Headache Attributed to Cranial or Cervical Vascular
Disorders
Headache Associated with Disorders of Homeostasis
Headache Caused by Disorders of the Cranium, Neck,
Eyes, Ears, Nose, Sinuses, Teeth, Mouth, or Other
Facial or Cranial Structures
Headaches and the Cervical Spine
Migraine
Chronic Daily Headache
Cluster Headache
Other Trigeminal Autonomic Cephalalgias
Other Primary Headaches
Cancer of the oral cavity accounts for approximately 3% of all malignancies diagnosed annually in 270,000 patients world-wide. Oral cancer is the 12th most common cancer in women and the 6th in men. Many oral squamous cell carcinomas develop from potentially malignant disorders (PMDs). Lack of awareness about the signs and symptoms of oral PMDs in the general population and even healthcare providers is believed to be responsible for the diagnostic delay of these entities.
Gingivitis is a form of gum disease characterised by reversible gingival inflammation without destruction of tooth-supporting tissues, periodontal ligament or bone
Headache Attributed to Nonvascular, Noninfectious
Intracranial Disorders
Headache Attributed to Trauma or Injury to the Head
and/or Neck
Headache Attributed to Infection
Headache Attributed to Cranial or Cervical Vascular
Disorders
Headache Associated with Disorders of Homeostasis
Headache Caused by Disorders of the Cranium, Neck,
Eyes, Ears, Nose, Sinuses, Teeth, Mouth, or Other
Facial or Cranial Structures
Headaches and the Cervical Spine
Migraine
Chronic Daily Headache
Cluster Headache
Other Trigeminal Autonomic Cephalalgias
Other Primary Headaches
Trigeminal neuralgia is sudden, severe facial pain. It's often described as a sharp shooting pain or like having an electric shock in the jaw, teeth or gums.
Trigeminal neuralgia
Contents
Overview
Symptoms
Causes
Diagnosis
Treatment
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. Outline
Introduction
Sensory disturbances of face
Classifications of nerve injury
Trigeminal neuralgia
Motor disturbances of face and jaws
Bells palsy
2
5. Sensory disturbances of face and
jaws
Impaired sensation
Allodynia
Analgesia
Anesthesia
Dysesthesia
Neuralgia
Neuritis
Protopathia
Causalgia
5
6. Etiology
Surgical procedures
Removal of impacted tooth
Orthognathic surgery
Endodontic and periradicular surgery
Endosseous dental implant placement
Salivary duct and gland surgery
Treatment of benign and malignant lesions
Facial trauma
6
7. Nerve injury classification
Seddon classification
Neurapraxia:
Mild, temporary injury
Compression or retraction of nerve
No axonal degeneration
Rapid and complete recovery
No surgical intervention required
7
8. Cont…
Axonotmesis:
Disruption or loss of continuity of some axons
General structure of nerve remains intact
Prolonged conduction failure
Initial signs of recovery > 3 months
Eventual recovery is often less than normal
(paresis, hypoesthesia)
8
9. Cont…
Neurotmesis
Complete severance or disruption of all layers
Wallerian degeneration of all axons
Total permanent conduction block of all impulses
Likely subsequent neuroma formation
No recovery is expected without surgical
intervention
9
10. Cont…
Sunderland classification
10 lesion (type I,II,III)
20 lesion: axonal injury with subsequent degeneration
and regeneration
30 lesion: endoneurial sheath is breached resulting in
intrafascicular disorganization
40 lesion: disruption of axon, endoneurium and
perineurium with preservation of continuity of
epineurium
50 lesion: severe disruption of connective tissue
10
15. Cont…
Indications for
microneurosurgery:
Observed nerve
severance
Total anesthesia beyond
3 months
Dysesthesia beyond 4
months
Contraindications
microneurosurgery:
Central neuropathic
pain
Dysesthesia not
abolished by LA nerve
block
Improving sensation
Sensory deficit
acceptable to the
patient
Metabolic neuropathy15
16. Trigeminal neuralgia
Neuropathic pain of trigeminal nerve origin, "tic
douloureux”
Sudden, usually unilateral, severe, brief, stabbing,
lancinating, paroxysmal, recurring pain in the
distribution of one or more branches of TN
Pain is intense, lasting for brief periods followed by a
refractory period
16
17. Epidemiology
Over 50 years of age
Incidence 8:100,000
Female-to-male ratio 1.6:1
Predilection for right side is noted (60%)
V3 more involved than V2 and rarely V1
17
19. Cont…
Compression or other pathology in the nerve leads
to demyelination
Fibers that do not themselves carry pain sensation
but become hyperexcitable and electrically
coupled with smaller unmyelinated or poorly
myelinated pain fibers in close proximity
Ectopic generation of action potentials in pain-
sensitive afferent fibers19
20. Clinical characteristics
No abnormal neurologic deficit
Elicited by slight touch to trigger points
Usually confined to one part of one division
Pain rarely crosses the midline
Pain is of short duration, but may recur with
variable frequency
20
21. Cont…
Refractory period between attacks, some patients
report a dull ache
Paroxysms occur in cycles, each cycle lasting for
weeks or months
In extreme cases, patient will have a motionless
face—the ‘frozen or mask like face’
Oral hygiene is usually poor
21
22. Cont…
Trigger zones
Corner of lips
Cheek
Ala of nose
Supra orbital ridge
Any intraoral site
Attacks do not occur during sleep
Early remissions of greater than 6 months before
return of active pain in half of patient
22
23. DIAGNOSIS
Well taken history
Proper clinical examination
Injections of local anesthetic agent into trigger
zone
All patients should ideally have MRI or at least a
CT scan
23
24. Protocol for diagnostic local anesthetic
peripheral nerve blocks
Often results in an immediate reduction in TN
attacks
Allows the patient to talk and provides practical
way
Eliminate the bouts of pain for prolonged time
Material Required
3–1 cc syringes
3–25 gauge needles
24
25. Cont…
Sweet Criteria
Paroxysmal
Provoked by light touch to face (trigger zones)
Confined to trigeminal nerve distribution
Unilateral
Clinical sensory examination is normal
25
26. ICHD criteria for classical TN
A. Paroxysmal attacks of pain, lasting from a second
to 2 minutes, affecting one or more divisions and
fulfilling criteria B and C
B. Pain has at least one of the following
characteristics:
Intense, sharp, superficial or stabbing
Precipitated from trigger areas or by trigger
factors
26
27. ICHD criteria for symptomatic TN
A. Paroxysmal attacks of pain,lasting from a second
to 2 minutes, affecting one or more divisions and
fulfilling criteria B and C
B. Pain has at least one of the following
characteristics:
Intense, sharp, superficial or stabbing
Precipitated from trigger areas or by trigger
factors27
28. Differential diagnosis
Primary somatic pain
Migraine or cluster headache
Temporal arteritis
Multiple sclerosis
Mass lesions: Aneurysms, neurofibromas, acoustic
schwannomas and meningioma
28
29. TREATMENT
Medical management
Modification of the paroxysmal pain at cortical
level
Antiepileptic drugs
Carbamezepin 400-1200
mg/day
Gabapentin 600-3200
mg/day
Baclofen 15-80 mg/day
Clonezepam 2-8 mg/day
Lamotrigine 50- 500 mg/day
Oxcarbazepine 300-2400
29
31. Cont…
Start with low dose of a single AED
Gradually escalate over subsequent days
Carbamazepine (Tegretol) primarily used- 100 mg
PO TID and titrated over 1 to 5 weeks period
More of daily drug dosage should be taken at
night
CBC, LFT should be done especially for high dose
taking patient31
32. Cont…
Multiple Drug therapy
When a patient only partially responds to single
drug therapy
There is little chance of success for additional third
drug
Careful reappraisal, including a critical reevaluation
diagnosis
If the diagnosis of TN is confirmed, such patients32
33. Surgical treatments
Peripheral neurectomy
Simple, can be repeated and relatively reliable
It acts by interrupting flow of afferent impulses
Indicated in patients, in whom craniotomy, a
more extensive procedure is contraindicated
Nerve end should be cauterized or redirected
Disadvantages - Full anesthesia or deep
hypoesthesia, neuroma formation33
34. Recent surgical approaches
Percutaneous stereotactic radiofrequency thermal
lesioning of trigeminal ganglion
Posterior fossa exploration and microvascular
decompression of the trigeminal root, and
Gamma knife radiation to trigeminal nerve root
entry zone
34
35. Motor disturbances of face and jaws
Paresis: weakness of muscles to perform motor
functions
Paralysis: total flaccidity of muscles to perform
motor functions
Altered motor function of the lips, cheeks, forehead
and eyelids produces significant problems in the
affected individual
35
37. Facial palsy is commonly unilateral
It may be either:
Peripheral: lesion of the facial nerve
Nuclear: destruction of the facial nucleus
Cereblar or supranuclear: injury to the brain or
from the injury to the face area of the motor
cortex itself
Cont…
37
38. House-Brackmann classification
Grade I : Normal function without weakness
Grade II : Mild dysfunction with slight facial
asymmetry
with a minor degree of synkinesis
Grade III : Moderate dysfunctions—obvious, but not
disfiguring, asymmetry with contracture or hemifacial
spasm, but residual forehead movement
38
39. Grade IV : Moderately severe dysfunction–
obvious, disfiguring asymmetry with lack of
forehead
motion and incomplete eye closure
Grade V : Severe dysfunction—asymmetry at rest
and only slight facial movement
Grade VI : Total paralysis—complete absence of
tone or motion
Prognosis is dependent on grade of severity39
40. Bell’s Palsy
Acute peripheral facial nerve palsy of unknown
cause
Sudden onset
Not related to any other disease elsewhere in the
body
Most common cause of unilateral facial paralysis
40
41. Incidence: 13 to 34 cases per 100,000 population
Sex predilection: More in female
3x more in pregnant women
Age: middle aged people
Positive family hx reported in about 8%
Epidemiology
41
42. Viral hypothesis: subclinical herpes simplex or
herpes zoster
Combination of facial palsy and herpes is
known as the Ramsay Hunt syndrome
Herpetic eruptions may occur on the skin, ear,
tympanic membrane, palate, face, soft palate
and tongue
Etiology
42
43. Ischemic hypothesis: ischemia from disturbed
circulation in the vasoneurosum
Genetic predisposition
Cont…
43
44. Clinical Features
Abrupt loss of muscular control on one side of the
face
Usually after awakening early in the morning
Unilateral involvement of entire side of the face
Inability to smile, close the eye or raise the
eyebrow on the affected side
Drooling of saliva
Loss or alteration of taste
Loss of blinking reflex44
45. Paralysis of facial muscles, with or without loss of
taste or altered secretion
Onset is acute; the course is progressive,
reaching maximal clinical weakness/paralysis
within three weeks or less and recovery or some
degree of function is present within six months
Associated prodrome, ear pain, or dysacusis is
variable
Diagnosis
45
46. Initially unilateral facial weakness affecting all
parts of the facial musculature
Gradually worsens over 2 to 3 days, reaching a
maximum in about 2 weeks
Remission begins within three weeks of onset in
85% of cases
Spontaneous recovery is known to occur in Bell’s
palsy
Prognosis
46
48. Medication: within 2 to 3 weeks of onset of
symptoms prednisolone in doses of 1 mg/kg/d for
10 to 14 days with a gradual tapering
If the patient is seen after 3 to 4 weeks, then
steroid therapy is of no use
Antiviral therapy (optional)
Cont…
48
49. If incomplete eye closure is present, artificial
lubrication, taping the eye, gold weight or
tarsorrhaphy might prevent visual loss from
exposure keratitis
Cont…
49
50. Internal decompression—the nerve is exposed in
fallopian canal and pressure in canal is relieved
by exposing the nerve
External decompression—is done by releasing of
epineural sheath from surrounding scar tissue,
bone or a foreign body
Currently not recommended
Surgical decompression
50